that cardiac glycosides inhibit the re-entry of potassium from the plasma into cold-stored erythrocytes and that the normal influx of potassium into the cells from the plasma of fresh blood incubated at 37#{176} can be almost abolished by the presence of cardiac glycosides (1) . The normal efflux of potassium from the cells under these conditions is not inhibited and the cells show a net loss of potassium.
The concentrations of glycosides required to produce 50 per cent inhibition vary from 4 X 10 molar in the case of ouabain to 1.2 X 10 molar in the case of digitoxin (2) . There is some evidence that adrenal steroids cause an increase in erythrocyte potassium in vivo due to an increase in potassium influx into the cell (3). In cardiac failure the level of aldosterone in the blood is increased and returns towards normal following cardiac compensation.
There are, therefore, two possible mechanisms which might be expected to produce a fall in the erythrocyte potassium level in patients with cardiac failure treated with glycosides.
In patients under treatment for cardiac failure the diminished production of adrenal steroids associated with the improvement in the cardiac condition and the direct action of cardiac glycosides on the erythrocytes might both be expected to cause a drop in the erythrocyte potassium.
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The investigation here reported shows that such a drop in erythrocyte potassium does occur and suggests that this phenomenon may be of use in the management of such cases.
METHOD OF INVESTIGATION
Fourteen patients in congestive heart failure without previous digitalis treatment were studied. The first sample of blood was drawn on admission to the hospital.
Two sets of controls were used. One consisted of 27 observations on a group of ten patients without known cardiovascular disease. lEn this group also the first sample of blood was drawn on admission to the hospital. The second group of controls consisted of 10 healthy adults whose erythrocyte potassium was estimated on each of five successive days. With the exception of the initial sample from those admitted to the hospital all bloods were drawn in the morning without regard to the state of alimentation.
The erythrocyte potassiums were determined from the potassium content of heparinized whole blood, the potassium content of the serum and the hematocrit.
The potassium determinations were made with a flame photometer and the hematocrit was determined by centrifuging 30 minutes at 1800 G. No attempt was made to correct for the potassium of the trapped plasma. Most of the determinations were made in duplicate.
RESULTS
The results on the treated patients are shown in Table 1 . Figure 1 shows the differences from the initial value of erythrocyte potassium in each of the three groups on five consecutive days.
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If the results are classified according to whether there is a rise or fall from the initial value and the chi-square procedure is applied, the tendency of the hospitalized controls to show an elevation above the initial level is found to be not significant (p>O.OS), whereas the marked tendency of the erythrocyte potassium in the treated group to fall is significant (p = 0.0014).
In all the treated cases a fall in erythrocyte potassium was associated with satisfactory clinical response to treatment. Those cases which showed no change or a rise in erythrocyte potassium immediately following administration of Gitaligin (Cases 2, 6, 11, and 14) did not show clinical compensation and digitalis therapy was intensified. The erythrocyte potassium in all cases eventually dropped below the initial value, and the patient simultaneously showed a satisfactory clinical response.
The usefulness of the determination of the erythrocyte potassium changes in the management of cardiac failure is being further investigated.
SUMMARY
The erythrocyte potassium shows a marked and statistically highly significant tendency to fall when patients with cardiac failure are treated with digitalis.
In the small series reported here there appears to be a correlation between clinical response and the fall of erythrocyte potassium. It is suggested that the determination of the erythrocyte potassium may be of value in the management of such cases.
